Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

Go back to Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
(NASDAQ: JAGX) Delayed: 2.56 -0.05 (1.92%)
Previous Close $2.61    52 Week High $4.60 
Open $2.50    52 Week Low $0.81 
Day High $2.64    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 103,109